318010 — Pharmsville Co Income Statement
0.000.00%
- KR₩28bn
- -KR₩10bn
- KR₩17bn
- 68
- 47
- 20
- 41
Annual income statement for Pharmsville Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 39,409 | 39,028 | 26,113 | 21,395 | 16,725 |
Cost of Revenue | |||||
Gross Profit | 27,448 | 25,782 | 15,843 | 13,162 | 10,519 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 35,102 | 32,868 | 22,050 | 19,762 | 17,396 |
Operating Profit | 4,306 | 6,159 | 4,063 | 1,633 | -671 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 3,442 | 6,164 | 5,192 | 3,966 | 1,830 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2,870 | 4,996 | 4,064 | 3,307 | 1,583 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 2,891 | 5,000 | 4,063 | 3,310 | 1,583 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2,891 | 5,000 | 4,063 | 3,310 | 1,583 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 370 | 637 | 514 | 426 | 251 |
Dividends per Share |